People taking GLP-1 weight loss drugs like Ozempic started moving less

ScienceDaily·Jun 14

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

People taking GLP-1 weight loss drugs, such as Ozempic, have been found to be moving less. The effects and implications of these drugs are still being studied and understood, with ongoing research into their benefits, side effects, and potential long-term consequences. The use of GLP-1s is reportedly transforming approaches to weight loss and diabetes, but may also be associated with various concerns and uncertainties.

Full coverage

GLP-1s 101: What the science says about weight loss, side effects, safety

Stanford Medicine·Jun 29

Retatrutide, the newest weight-loss drug, helped people lose 30% of body weight, on par with weight-loss surgery

UCHealth·Jun 16

People Using GLP-1s, Like Ozempic, Wegovy, Less Likely to Exercise Despite Benefits

Healthline·Jun 13

What We Know About Weight-Loss Drugs Is Rapidly Changing

The New York Times·Jun 8

Ozempic skin side effects are more common than you think — here's what dermatologists say actually helps

Yahoo Health·4d ago

GLP-1s have transformed weight loss and diabetes. Is addiction next?

NPR·Mar 10

Stopping and restarting certain GLP-1s to lose weight may make the drug less effective

Penn Medicine·Apr 28

People Are Sharing The Things They Think Will Be “Inevitable Outcomes” Of GLP-1s Over The Next 20 Years

BuzzFeed·5d ago

View original report at ScienceDaily ↗

Fetching the latest headlines…